BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26808432)

  • 1. Canine Cutaneous and Subcutaneous Soft Tissue Sarcoma: An Evidence-Based Review of Case Management.
    Hohenhaus AE; Kelsey JL; Haddad J; Barber L; Palmisano M; Farrelly J; Soucy A
    J Am Anim Hosp Assoc; 2016; 52(2):77-89. PubMed ID: 26808432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles of treatment for soft-tissue sarcomas in the dog.
    Ettinger SN
    Clin Tech Small Anim Pract; 2003 May; 18(2):118-22. PubMed ID: 12831074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of treatment for soft tissue sarcoma.
    Dernell WS; Withrow SJ; Kuntz CA; Powers BE
    Clin Tech Small Anim Pract; 1998 Feb; 13(1):59-64. PubMed ID: 9634350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
    Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of pre-treatment biopsy for grading soft tissue sarcomas in dogs.
    Perry JA; Culp WT; Dailey DD; Eickhoff JC; Kamstock DA; Thamm DH
    Vet Comp Oncol; 2014 Jun; 12(2):106-13. PubMed ID: 22617002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
    Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
    J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft-tissue sarcomas in dogs: a review.
    Ehrhart N
    J Am Anim Hosp Assoc; 2005; 41(4):241-6. PubMed ID: 15995161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective comparison of carbon dioxide surgical laser and non-laser excision for removal of cutaneous and subcutaneous soft-tissue sarcomas in dogs.
    Agulian L; Mann FA; Middleton JR; Kim DY
    N Z Vet J; 2020 Nov; 68(6):340-344. PubMed ID: 32529958
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.
    Milovancev M; Townsend KL; Tuohy JL; Gorman E; Bracha S; Curran KM; Russell DS
    Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
    Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
    Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005-2012).
    Prpich CY; Santamaria AC; Simcock JO; Wong HK; Nimmo JS; Kuntz CA
    J Am Vet Med Assoc; 2014 Jan; 244(2):187-94. PubMed ID: 24378028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft tissue sarcomas in dogs.
    Mayer MN; LaRue SM
    Can Vet J; 2005 Nov; 46(11):1048, 1050, 1052. PubMed ID: 16363335
    [No Abstract]   [Full Text] [Related]  

  • 13. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.
    Elmslie RE; Glawe P; Dow SW
    J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
    McSporran KD
    Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grade shifts in recurrent canine soft tissue sarcomas and mast cell tumors.
    Griffin MA; Hughes K; Altwal J; Seguin B; Wustefeld-Janssens B
    J Am Vet Med Assoc; 2023 Sep; 261(9):1-8. PubMed ID: 37257826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of information presented within soft tissue sarcoma histopathology reports in the United States: 2012-2015.
    Livaccari AM; Selmic LE; Reagan JK; Driskell EA; Cray MT; Lamoureux LM; Garrett LD
    Vet Comp Oncol; 2018 Dec; 16(4):424-430. PubMed ID: 29575744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in tumor margin reporting for soft tissue sarcoma and cutaneous mast cell tumors in dogs: A systematic review.
    Abrams BE; Putterman AB; Ruple A; Wavreille V; Selmic LE
    Vet Surg; 2021 Feb; 50(2):259-272. PubMed ID: 33331059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term outcome following surgical excision of large, low to intermediate grade soft tissue sarcomas in dogs.
    Davis A; Hosgood G
    Aust Vet J; 2023 May; 101(5):193-199. PubMed ID: 36751015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).
    Bergman NS; Urie BK; Pardo AD; Newman RG
    J Am Vet Med Assoc; 2016 May; 248(10):1148-56. PubMed ID: 27135671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between cytologic features and histologic grades in cutaneous and subcutaneous soft tissue sarcomas in dogs-A pilot study.
    Sanchez-Redondo S; Hare CHZ; Constantino-Casas F; Williams TL
    Vet Clin Pathol; 2021 Jun; 50(2):236-239. PubMed ID: 33797110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.